Delivery Order SPE2DB22D3016-SPE2DB24FAPV2
Award Date 3/13/24
Potential Completion Date 4/3/24
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,103.66 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of March 8, 2024 and was awarded on February 15, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,585.02, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, under a Firm Fixed Price delivery order. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of medical supplies, including the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML. The $12,792.51 firm-fixed-price delivery order falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which enables the company to supply a wide range of...
- This federal contract award, valued at $25,151.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a specialty medication, with a completion date of December 19, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award, with the ID SPE2DB22D3016|SPE2DB24FAZS3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $24,310.92 and a completion date of July 22, 2024. AmerisourceBergen Drug Corp, the prime contractor, is the Corporate Office division of AmerisourceBergen Corporation, one of the largest...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of VYVGART 400 MG/20 ML VIAL 20ML. The contract has a ceiling value of $8,528.34 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of July 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense...
- This federal contract award is a delivery order (SPE2DB22D3016|SPE2DB24FBFW5) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVGART 400 MG/20 ML VIAL 20ML. The contract has a ceiling value of $32,414.56 and is a firm fixed-price arrangement. The award date is September 3, 2024, and the ultimate completion date is September 24, 2024. This delivery order is placed under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vyvgart 400 mg/20 ml vials. The contract is non-set-aside and competitively awarded with firm fixed pricing, with an ultimate completion date of September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,844.28 firm fixed-price delivery order covers a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of November 25, 2024....
- This federal contract award, with the ID SPE2DX22D0040|SPE2D825FA4VR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,541.93 firm fixed-price delivery order contract, which has a March 13, 2025 completion date, is for the provision of a variety of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAPV2Delivery Order
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FAPV2, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $16,207.28 firm fixed price delivery order is for the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with a completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Generated 6/12/24, 10:21 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 3/13/24 |